Verona Pharma PLC (VRNA)
35.64
+0.28
(+0.78%)
USD |
NASDAQ |
Nov 15, 16:00
35.64
0.00 (0.00%)
After-Hours: 16:48
Verona Pharma Free Cash Flow (Quarterly): -62.66M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -62.66M |
| June 30, 2024 | -17.13M |
| March 31, 2024 | -13.63M |
| December 31, 2023 | -10.40M |
| September 30, 2023 | -12.73M |
| June 30, 2023 | -21.31M |
| March 31, 2023 | -5.782M |
| December 31, 2022 | -7.738M |
| September 30, 2022 | -18.10M |
| June 30, 2022 | -19.55M |
| March 31, 2022 | -14.51M |
| December 31, 2021 | -17.32M |
| September 30, 2021 | 22.81M |
| June 30, 2021 | -20.20M |
| March 31, 2021 | -18.55M |
| December 31, 2020 | -18.80M |
| Date | Value |
|---|---|
| September 30, 2020 | -10.06M |
| June 30, 2020 | -3.061M |
| March 31, 2020 | -13.23M |
| December 31, 2019 | -11.35M |
| September 30, 2019 | -8.521M |
| June 30, 2019 | -10.11M |
| March 31, 2019 | -12.95M |
| December 31, 2018 | -6.003M |
| September 30, 2018 | -0.9495M |
| June 30, 2018 | -7.431M |
| March 31, 2018 | -8.937M |
| December 31, 2017 | -6.873M |
| September 30, 2017 | -10.62M |
| June 30, 2017 | -6.272M |
| March 31, 2017 | -4.494M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-62.66M
Minimum
Sep 2024
22.81M
Maximum
Sep 2021
-14.66M
Average
-14.07M
Median
Free Cash Flow (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 46.64M |
| Biodexa Pharmaceuticals PLC | -- |
| NuCana PLC | -1.569M |
| TC BioPharm (Holdings) PLC | -3.062M |
| Autolus Therapeutics PLC | -51.92M |